 ImmunoPrecise Antibodies Ltd NASDAQ:IPA is surging higher Thursday after the company highlighted the ability of its antibody cocktail to potentially neutralize COVID-19 variants. ImmunoPrecise Antibodies antibody cocktail, TATX-03 PolyTope, was developed for the potential prevention and treatment of SARS-CoV-2. 